This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Jul;13(7):638-9.

doi: 10.1016/S1474-4422(14)70100-0. Epub 2014 May 28.

Interferon β-1a for multiple sclerosis: old drug, new clothes

Hans-Peter Hartung¹

Affiliations

PMID: 24878062
DOI: 10.1016/S1474-4422(14)70100-0

Comment

Interferon β-1a for multiple sclerosis: old drug, new clothes

Hans-Peter Hartung. Lancet Neurol. 2014 Jul.

. 2014 Jul;13(7):638-9.

doi: 10.1016/S1474-4422(14)70100-0. Epub 2014 May 28.

Author

Hans-Peter Hartung¹

Affiliation

¹ Department of Neurology, Heinrich-Heine-University, D-40225 Düsseldorf, Germany. Electronic address: hans-peter.hartung@uni-duesseldorf.de.

PMID: 24878062
DOI: 10.1016/S1474-4422(14)70100-0

No abstract available

PubMed Disclaimer

Comment on

Pegylated interferon β-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study.
Calabresi PA, Kieseier BC, Arnold DL, Balcer LJ, Boyko A, Pelletier J, Liu S, Zhu Y, Seddighzadeh A, Hung S, Deykin A; ADVANCE Study Investigators. Calabresi PA, et al. Lancet Neurol. 2014 Jul;13(7):657-65. doi: 10.1016/S1474-4422(14)70068-7. Epub 2014 Apr 30. Lancet Neurol. 2014. PMID: 24794721 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations